Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.
|Videos|May 11, 2021
Dr. Kate Kraft discusses her path to urology
Author(s)Urology Times staff
“I really fell in love with [urology] from the get go,” Kraft says.
Advertisement
In this video, Kate H. Kraft, MD, also shares her advice for female medical students who are considering pursuing urology. Kraft is an assistant professor of urology and residency program director for urology at the University of Michigan, Ann Arbor.
Advertisement
Related to this article
Aaron Berger, MD, discusses patient selection for ARPI treatment holidays, monitoring during interruptions, and the role of testosterone recovery in interpreting PSA kinetics.
Paras H. Shah, MD, recaps data on emerging agents in high-risk NMIBC from the 2026 AUA North Central Section Meeting.
Tamim Niazi, MDCM, reviews DASL-HiCaP findings showing improved metastasis-free survival with darolutamide added to ADT and radiation therapy.
Chad Ritch, MD, discusses differences between PSMA-PET imaging agents and the need for further evidence to guide clinical decision-making.
Chad Ritch, MD, discusses how PSMA-PET informs patient management across different stages of the prostate cancer journey.
Alicia K. Morgans, MD, MPH, reviews promising prostate cancer findings from ESMO 2026,
Alberto Briganti, MD, PhD, discusses results from the PROTEUS substudy, evaluating perioperative apalutamide plus ADT vs surgery alone in high-risk localized or locally advanced prostate cancer.
Advertisement
Advertisement
Trending on Urology Times
1
Tamim Niazi, MDCM, reviews darolutamide data from DASL-HiCaP
2
2026 AUA North Central Section Meeting: Updates in high-risk NMIBC
3
FDA updates in urology: October 2026
4
UGN-101 shows durable responses in low-grade upper tract urothelial carcinoma
5